advertisement

WGC-2021

11.16 Vehicles, delivery systems, pharmacokinetics, formulation (2056)

Showing records 1 to 25

Display only abstracts from IGR 20-4 in classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation

Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation

84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Yagi-Yaguchi Y
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)


84144 Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study
Emad Eldeeb A
Drug Delivery 2019; 26: 509-521 (IGR: 21-1)


85151 Mitochondrial Dysfunctions May Be One of the Major Causative Factors Underlying Detrimental Effects of Benzalkonium Chloride
Rogov AG
Oxidative medicine and cellular longevity 2020; 2020: 8956504 (IGR: 21-1)


85206 Promising therapeutic drug delivery systems for glaucoma: a comprehensive review
Singh RB
Therapeutic advances in ophthalmology 2020; 12: 2515841420905740 (IGR: 21-1)


85049 The Sustained Release of Tafluprost with a Drug Delivery System Prevents the Axonal Injury-induced Loss of Retinal Ganglion Cells in Rats
Sato K
Current Eye Research 2020; 0: 1-10 (IGR: 21-1)


84877 Ocular surface analysis and automatic non-invasive assessment of tear film breakup location, extension and progression in patients with glaucoma
Guarnieri A
BMC Ophthalmology 2020; 20: 12 (IGR: 21-1)


85091 Clinical Evaluation of a Novel Electromechanical Topical Ocular Drug Delivery System: Two Phase 1 Proof of Concept Studies
Quiroz-Mercado H
Clinical Ophthalmology 2020; 14: 139-147 (IGR: 21-1)


84508 Effects of topical autologous serum on the ocular surface in patients with toxic corneal epitheliopathy induced by anti-glaucoma drugs
Yoon CH
International Ophthalmology 2020; 40: 547-552 (IGR: 21-1)


84927 Bimatoprost Imprinted Silicone Contact Lens to Treat Glaucoma
Yan F
AAPS PharmSciTech 2020; 21: 63 (IGR: 21-1)


84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Zhang F
Drug Delivery 2019; 26: 812-819 (IGR: 21-1)


84572 Dendritic Effects of Injectable Biodegradable Thermogels on Pharmacotherapy of Inflammatory Glaucoma-Associated Degradation of Extracellular Matrix
Nguyen DD
Advanced healthcare materials 2019; 8: e1900702 (IGR: 21-1)


84579 Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study
Dubey V
International Journal of Biological Macromolecules 2019; 0: (IGR: 21-1)


85115 Albumin Levels in Tear Film Modulate the Bioavailability of Medically-Relevant Topical Drugs
Sebbag L
Frontiers in pharmacology 2019; 10: 1560 (IGR: 21-1)


84963 Brinzolamide Dimethyl Sulfoxide In Situ Gelling Ophthalmic Solution: Formulation Optimisation and In Vitro and In Vivo Evaluation
Bhalerao H
AAPS PharmSciTech 2020; 21: 69 (IGR: 21-1)


84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Craven ER
Drugs 2020; 80: 167-179 (IGR: 21-1)


84572 Dendritic Effects of Injectable Biodegradable Thermogels on Pharmacotherapy of Inflammatory Glaucoma-Associated Degradation of Extracellular Matrix
Nguyen DD
Advanced healthcare materials 2019; 8: e1900702 (IGR: 21-1)


84893 Sustained Nitric Oxide-Providing Small Molecule and Precise Release Behavior Study for Glaucoma Treatment
Jeong H
Molecular pharmaceutics 2020; 17: 656-665 (IGR: 21-1)


85206 Promising therapeutic drug delivery systems for glaucoma: a comprehensive review
Singh RB
Therapeutic advances in ophthalmology 2020; 12: 2515841420905740 (IGR: 21-1)


84655 Benzoic acid derivative-modified chitosan-g-poly(N-isopropylacrylamide): Methoxylation effects and pharmacological treatments of Glaucoma-related neurodegeneration
Luo LJ
Journal of Controlled Release 2020; 317: 246-258 (IGR: 21-1)


85089 Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
Mylla Boso AL
Clinical Ophthalmology 2020; 14: 103-111 (IGR: 21-1)


85206 Promising therapeutic drug delivery systems for glaucoma: a comprehensive review
Ichhpujani P
Therapeutic advances in ophthalmology 2020; 12: 2515841420905740 (IGR: 21-1)


84572 Dendritic Effects of Injectable Biodegradable Thermogels on Pharmacotherapy of Inflammatory Glaucoma-Associated Degradation of Extracellular Matrix
Luo LJ
Advanced healthcare materials 2019; 8: e1900702 (IGR: 21-1)


84877 Ocular surface analysis and automatic non-invasive assessment of tear film breakup location, extension and progression in patients with glaucoma
Carnero E
BMC Ophthalmology 2020; 20: 12 (IGR: 21-1)


85089 Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
Gasperi E
Clinical Ophthalmology 2020; 14: 103-111 (IGR: 21-1)


84927 Bimatoprost Imprinted Silicone Contact Lens to Treat Glaucoma
Liu Y
AAPS PharmSciTech 2020; 21: 63 (IGR: 21-1)



Issue 20-4

Select Issue


advertisement

WGW-2021